{"id":"https://openalex.org/W166862232","doi":null,"title":"The COX-2 inhibitor market withdrawals and prescribing patterns by rheumatologists in patients with gastrointestinal and cardiovascular risk.","display_name":"The COX-2 inhibitor market withdrawals and prescribing patterns by rheumatologists in patients with gastrointestinal and cardiovascular risk.","publication_year":2009,"publication_date":"2009-05-01","ids":{"openalex":"https://openalex.org/W166862232","mag":"166862232","pmid":"https://pubmed.ncbi.nlm.nih.gov/19604430"},"language":"en","primary_location":{"id":"pmid:19604430","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19604430","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and experimental rheumatology","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030768494","display_name":"Jeffrey D. Greenberg","orcid":"https://orcid.org/0000-0001-9711-0457","observed_orcids":["https://orcid.org/0000-0001-9711-0457"]},"institutions":[{"id":"https://openalex.org/I4210163050","display_name":"New York University Langone Orthopedic Hospital","ror":"https://ror.org/05d789537","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933","https://openalex.org/I4210163050"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J D Greenberg","raw_affiliation_strings":["New York University Hospital for Joint Diseases, New York, NY 10003, USA. Jeffrey.Greenberg@nyumc.org"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York University Hospital for Joint Diseases, New York, NY 10003, USA. Jeffrey.Greenberg@nyumc.org","institution_ids":["https://openalex.org/I4210163050","https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109049024","display_name":"M Fisher","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M C Fisher","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014147030","display_name":"Joel M. Kremer","orcid":"https://orcid.org/0000-0001-6674-9901","observed_orcids":["https://orcid.org/0000-0001-6674-9901"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Kremer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037657031","display_name":"Hong Chang","orcid":"https://orcid.org/0000-0002-6020-2726","observed_orcids":["https://orcid.org/0000-0002-6020-2726","https://orcid.org/0009-0001-4302-6046"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Chang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084152442","display_name":"Elliot D. Rosenstein","orcid":"https://orcid.org/0000-0001-7681-4615","observed_orcids":["https://orcid.org/0000-0001-7681-4615"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E D Rosenstein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036516738","display_name":"Mitsumasa Kishimoto","orcid":"https://orcid.org/0000-0002-4007-1589","observed_orcids":["https://orcid.org/0000-0002-4007-1589"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Kishimoto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003520331","display_name":"S Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020895246","display_name":"Yusuf Yaz\u0131c\u0131","orcid":"https://orcid.org/0000-0002-7605-5759","observed_orcids":["https://orcid.org/0000-0002-7605-5759"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y Yazici","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101493669","display_name":"Arthur Kavanaugh","orcid":"https://orcid.org/0000-0001-6942-5830","observed_orcids":["https://orcid.org/0000-0001-6942-5830"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Kavanaugh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009863149","display_name":"Steven B. Abramson","orcid":"https://orcid.org/0000-0002-0668-6344","observed_orcids":["https://orcid.org/0000-0002-0668-6344"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S B Abramson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.6332,"has_fulltext":false,"cited_by_count":27,"citation_normalized_percentile":{"value":0.81034885,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"27","issue":"3","first_page":"395","last_page":"401"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9804999828338623,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9804999828338623,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.01080000028014183,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.9800000190734863},{"id":"https://openalex.org/keywords/gastroprotective-effect","display_name":"gastroprotection","score":0.7680000066757202},{"id":"https://openalex.org/keywords/non-selective-nsaids","display_name":"non-selective NSAIDs","score":0.8370000123977661},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.8769999742507935},{"id":"https://openalex.org/keywords/psoriatic-arthritis","display_name":"psoriatic arthritis","score":1.0},{"id":"https://openalex.org/keywords/gastrointestinal-bleeding-risk","display_name":"gastrointestinal bleeding risk","score":0.8479999899864197},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.9879999756813049}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9634162187576294},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7637834548950195},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.6858551502227783},{"id":"https://openalex.org/C198451711","wikidata":"https://www.wikidata.org/wiki/Q327657","display_name":"Rheumatology","level":2,"score":0.6027941107749939},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.5973197817802429},{"id":"https://openalex.org/C2777031258","wikidata":"https://www.wikidata.org/wiki/Q377458","display_name":"COX-2 inhibitor","level":4,"score":0.5304391384124756},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.48338571190834045},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.46631938219070435},{"id":"https://openalex.org/C2776260265","wikidata":"https://www.wikidata.org/wiki/Q511097","display_name":"Psoriatic arthritis","level":3,"score":0.4219486117362976},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3662654161453247},{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D004363","descriptor_name":"Drug Utilization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005767","descriptor_name":"Gastrointestinal Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D005767","descriptor_name":"Gastrointestinal Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012042","descriptor_name":"Registries","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015535","descriptor_name":"Arthritis, Psoriatic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:19604430","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19604430","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and experimental rheumatology","raw_type":"Journal Article"},{"id":"mag:166862232","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19604430","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G826750296","display_name":"Prognostic Genetic Biomarkers in Rheumatoid Arthritis","funder_award_id":"K23AR054412","funder_id":"https://openalex.org/F4320337362","funder_display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases"}],"funders":[{"id":"https://openalex.org/F4320337362","display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","ror":"https://ror.org/006zn3t30"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1569096576","https://openalex.org/W1967276177","https://openalex.org/W1969077452","https://openalex.org/W1976434085","https://openalex.org/W1981816788","https://openalex.org/W1985210212","https://openalex.org/W1988108320","https://openalex.org/W1995528018","https://openalex.org/W1997661013","https://openalex.org/W2011327495","https://openalex.org/W2011941025","https://openalex.org/W2037942670","https://openalex.org/W2050784884","https://openalex.org/W2057685090","https://openalex.org/W2062738310","https://openalex.org/W2064493373","https://openalex.org/W2070469088","https://openalex.org/W2089015546","https://openalex.org/W2106346422","https://openalex.org/W2117935315","https://openalex.org/W2119935630","https://openalex.org/W2143995569","https://openalex.org/W2148359829","https://openalex.org/W2158310507","https://openalex.org/W2163756514","https://openalex.org/W2168733098","https://openalex.org/W2172253009","https://openalex.org/W2330496155","https://openalex.org/W3147046978"],"related_works":["https://openalex.org/W2064493373","https://openalex.org/W2089015546","https://openalex.org/W2118485616","https://openalex.org/W7080759355","https://openalex.org/W1972941389","https://openalex.org/W2110934108","https://openalex.org/W2369477003","https://openalex.org/W2119935630","https://openalex.org/W2262344997","https://openalex.org/W1617830605"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"examine":[2],"effects":[3],"of":[4,18,38,41,91,103,209,236],"the":[5,36,101,207,233],"COX-2":[6,92,123,178,190],"inhibitor":[7,93,124,179,191],"market":[8],"withdrawals":[9,192],"on":[10,71],"NSAID":[11,82,110,152,199,240],"utilization":[12,94,112,180,185],"among":[13,220],"patients":[14,33,57,144,166,221],"at":[15,222],"increased":[16,137,186,223],"risk":[17,107,149,172],"gastrointestinal":[19],"(GI)":[20],"and":[21,53,95,105,246],"cardiovascular":[22],"(CV)":[23],"toxicities.":[24,248],"METHODS:":[25],"A":[26],"prospective":[27],"cohort":[28],"study":[29,47],"was":[30,85,217],"conducted":[31],"using":[32],"enrolled":[34],"in":[35,116,121,160,194,198,239],"Consortium":[37],"Rheumatology":[39],"Researchers":[40],"North":[42],"America":[43],"(CORRONA)":[44],"Registry.":[45],"The":[46,74,189],"population":[48],"included":[49,89],"rheumatoid":[50],"arthritis":[51,55],"(RA)":[52],"psoriatic":[54],"(PsA)":[56],"prescribed":[58,201],"NSAIDs":[59,134],"by":[60,100,202],"rheumatologists":[61,205],"from":[62,114,127,138,158,174],"1/1/2003":[63],"to":[64,118,129,140,162,176,231],"12/31/2005.":[65],"Three":[66],"cohorts":[67],"were":[68],"defined":[69],"based":[70],"calendar":[72],"year.":[73],"primary":[75],"outcome":[76],"assessed":[77],"whether":[78],"or":[79,147,169],"not":[80],"an":[81],"gastroprotective":[83,96,211],"strategy":[84],"prescribed.":[86],"Secondary":[87],"outcomes":[88],"rates":[90],"co-therapy":[97],"utilization,":[98],"stratified":[99],"presence":[102],"cardiac":[104],"GI":[106,154,245],"factors.":[108],"RESULTS:":[109],"gastroprotection":[111,156,200],"decreased":[113,126,157,181],"65.1%":[115],"2003":[117,161,175],"47.7%":[119],"(p<0.001)":[120],"2005.":[122],"use":[125,136,216],"55.1%":[128],"29.2%":[130],"(p<0.001),":[131],"whereas":[132,183],"nonselective":[133],"(nsNSAIDs)":[135],"50.2%":[139],"73.9%":[141],"(p=<0.01).":[142],"Among":[143],"with":[145,167],"two":[146,168],"more":[148,170],"factors":[150,173],"for":[151,243],"related":[153],"bleeding,":[155],"74.4%":[159],"60.9%":[163],"(p<0.01).":[164],"For":[165],"CV":[171,224],"2005,":[177],"significantly,":[182],"nsNSAID":[184,215],"significantly.":[187],"CONCLUSIONS:":[188],"resulted":[193],"a":[195],"rapid":[196],"decline":[197],"participating":[203],"U.S.":[204],"despite":[206],"availability":[208],"other":[210],"options.":[212],"Channeling":[213],"toward":[214],"widespread,":[218],"including":[219],"risk.":[225],"Longer":[226],"term":[227],"follow-up":[228],"is":[229],"required":[230],"determine":[232],"clinical":[234],"significance":[235],"these":[237],"changes":[238],"prescribing,":[241],"particularly":[242],"NSAID-related":[244],"CV-related":[247]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}